enkephalin, d-penicillamine (2,5)- has been researched along with Colitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartoszek, A; Binienda, A; Dziedziczak, K; Fabisiak, A; Fichna, J; Kordek, R; Krajewska, JB; Makaro, A; Mosińska, P; Niewinna, K; Salaga, M; Świerczyński, M; Talar, M; Tarasiuk, A | 1 |
1 other study(ies) available for enkephalin, d-penicillamine (2,5)- and Colitis
| Article | Year |
|---|---|
Characterization of the Synergistic Effect between Ligands of Opioid and Free Fatty Acid Receptors in the Mouse Model of Colitis.
Topics: Aniline Compounds; Animals; Butyrates; Colitis; Disease Models, Animal; Drug Synergism; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Inflammation; Ligands; Male; Mice; Mice, Inbred BALB C; Naloxone; Narcotic Antagonists; Peroxidase; Receptors, G-Protein-Coupled; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, mu; Sulfonamides; Thiophenes; Xanthenes | 2021 |